Zealand Pharma's Petrelintide is a once-weekly long-acting amylin analogue advancing through Phase 2, joining Eloralintide and Cagrilintide in the amylin class.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.